TP53 and colorectal carcinoma: On the other hand, p53 is also able to prevent the formation of the cyclin B-CDK1 complex in G2 stage, before the cell’s entry into the mitotic phase, as for example shown in HCT-116 and DLD-1 CRC cells [138].